| Allegiant Travel (NASDAQ:ALGT) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $90.00 price target on the stock, down previously from $125.00. This represents a 64.9% upside from the current price of $54.59. |
| Compass Therapeutics (NASDAQ:CMPX) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $6.00 price target on the stock, up previously from $4.00. This represents a 181.0% upside from the current price of $2.14. |
| Equitable (NYSE:EQH) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $77.00 price target on the stock, up previously from $49.00. This represents a 41.5% upside from the current price of $54.41. |
| Fiserv (NYSE:FI) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $260.00 price target on the stock, up previously from $246.00. This represents a 15.9% upside from the current price of $224.38. |
| Hilltop (NYSE:HTH) was upgraded by analysts at Raymond James from an "underperform" rating to a "market perform" rating.The current price is $30.45. |
| IDACORP (NYSE:IDA) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating.The current price is $119.01. |
| Jack Henry & Associates (NASDAQ:JKHY) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $183.00 price target on the stock. This represents a 0.1% upside from the current price of $182.88. |
| Oceaneering International (NYSE:OII) was upgraded by analysts at Pickering Energy Partners from an "underperform" rating to a "neutral" rating.The current price is $22.40. |
| Reinsurance Group of America (NYSE:RGA) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $237.00 price target on the stock, up previously from $232.00. This represents a 19.7% upside from the current price of $197.99. |
| Rocket Companies (NYSE:RKT) was upgraded by analysts at Keefe, Bruyette & Woods from an "underperform" rating to a "market perform" rating. They now have a $14.00 price target on the stock. This represents a 3.2% downside from the current price of $14.46. |
| Rocket Companies (NYSE:RKT) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $16.00 price target on the stock. This represents a 10.6% upside from the current price of $14.46. |
| Charles Schwab (NYSE:SCHW) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $102.00 price target on the stock, up previously from $85.00. This represents a 30.5% upside from the current price of $78.15. |
| Scotts Miracle-Gro (NYSE:SMG) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $70.00 price target on the stock. This represents a 23.6% upside from the current price of $56.65. |
| Sportsman's Warehouse (NASDAQ:SPWH) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $3.00 price target on the stock. This represents a 69.1% upside from the current price of $1.77. |
| Surf Air Mobility (NYSE:SRFM) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $3.25 price target on the stock, down previously from $3.75. This represents a 24.8% upside from the current price of $2.61. |
| Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by analysts at HC Wainwright from a "sell" rating to a "neutral" rating. They now have a $75.00 price target on the stock. This represents a 19.2% upside from the current price of $62.90. |
| SouthState (NASDAQ:SSB) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $115.00 price target on the stock, down previously from $120.00. This represents a 23.7% upside from the current price of $92.98. |
| Takeda Pharmaceutical (NYSE:TAK) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating.The current price is $14.98. |
| Atlassian (NASDAQ:TEAM) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $272.00 price target on the stock, down previously from $304.00. This represents a 23.6% upside from the current price of $220.07. |
0 comments:
Post a Comment